Sucampo Pharmaceuticals, Inc. (SCMP) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Income tax benefit (provision): -7.41M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Income tax benefit (provision): -7.41M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) reported Q1 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $24.19 million.
For earnings history and earnings-related data on Sucampo Pharmaceuticals, Inc. (SCMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Western Digital (WDC) Tops Q3 EPS by 42c; offers guidance
- T-Mobile posts mixed Q1 top and bottom line, expects more subscribers in 2024
- Exponent, Inc. (EXPO) Tops Q1 EPS by 12c, provides outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
